CING - ADHD-Focused Cingulate Prices Public Offering Shares Detailed Pivotal Trial Data | Benzinga
Cingulate Inc (NASDAQ: CING) shares are trading lower after the company priced its $4-million public offering at around 58 cents per share and accompanying warrants.
The offering includes 6.93 million shares and Series A and Series B warrants to purchase up to 6.93 million and up to 3.46 million shares, respectively.
Series A and Series B warrants have an exercise price of 57 cents per share.
The Kansas City, Kansas-based company also announced full results from ...